Vitality Watch

Dossier pubmed review 03-nov-2026
Narrative review or expert overview without new data

Evidence for spermine oxidase (SMOX) as a regulator of skeletal muscle mass throughout the lifespan.

Key claim: Spermine oxidase (SMOX) preserves skeletal muscle mass and function throughout aging by generating spermidine, suppressing cellular senescence markers, and restoring satellite cell autophagy.

Abstract

Age-associated loss of muscle mass and function, termed sarcopenia, increases morbidity and mortality risks concomitant with decreased physical activity. Chronic exercise training is the most effective countermeasure against sarcopenia, but physical limitations create a barrier to participation in the elderly. Investigation into alternative pharmaceutical and nutraceutical treatments to prevent sarcopenia and maintain muscle plasticity late-in-life are therefore warranted. Polyamine metabolism regulates many facets of skeletal muscle biology with the potential for targeted treatments in conditions of compromised muscle health and plasticity. Particularly, spermidine is shown to benefit muscle health in mammalian models of ageing and exercise training. Endogenous production of spermidine is partially regulated by the enzyme spermine oxidase (SMOX). SMOX catabolism cleaves spermine into spermidine to maintain a healthy polyamine pool. Anabolic signaling regulates SMOX expression suggesting a supporting role of polyamines during muscle hypertrophy. SMOX overexpression in skeletal muscle retains muscle fiber size in atrophy-inducing animal models (e.g. immobilization, fasting, denervation) potentially driven by reciprocal downregulation of p21, a marker of cellular senescence. In satellite cells, spermidine improves satellite cell function by restoring autophagy and mitophagy, potentially related to anti-ageing Yamanaka factors. Abundance of SMOX is highest in fast-twitch muscle fiber types but can respond in a fiber-type and exercise dependent manner. In humans, higher basal SMOX expression after strength training correlates to higher strength gains, but investigations of SMOX’s actions in humans are lacking. Further defining the role of SMOX in animal and human models will facilitate future skeletal muscle-specific therapeutics to promote youthfulness during ageing.

Why this matters

The review [expert-opinion] places endogenous polyamine metabolism upstream of muscle maintenance, linking SMOX-mediated spermidine production with satellite-cell autophagy and senescence-associated readouts. This synthesis does not establish the proposed causal chain in aging humans, and its therapeutic framing does not demonstrate that increasing SMOX activity or taking spermidine prevents sarcopenia [expert-opinion].

Source

Link

Briefing card

Evidence for spermine oxidase (SMOX) as a regulator of skeletal muscle mass throughout the lifespan.
Stage: review · pubmed · 03-nov-2026

If you take spermidine for muscle preservation, this review does not establish that supplementation prevents age-related muscle loss in humans.

Spermine oxidase (SMOX) preserves skeletal muscle mass and function throughout aging by generating spermidine, suppressing cellular senescence markers, and restoring satellite cell autophagy.

Cross-references (0)

None recorded — doctrine links and citations appear here as scans and citation sweeps find them.

External: doi:10.1016/j.arr.2026.103437

build build 880 · 2bcef25 · 2026-11-18